Reactive Arthropathies

Definition And Overview

• Sterile inflammatory arthritis occurring simultaneously or following distant extra-articular infection.
• Categorized under seronegative spondyloarthropathies.
• Major subtypes include classical reactive arthritis (genitourinary or gastrointestinal triggers), post-streptococcal reactive arthritis (PSReA), and post-infectious viral arthritis.

Epidemiology And Genetics

Demographics

• Peak incidence occurs in children aged 8-12 years.
• Equal sex ratio initially, shifting to male predominance in older adolescents due to sexually transmitted infections.
• Prevalence depends on community exposure to arthritogenic bacteria and genetic susceptibility.

Genetic Associations

• Human Leukocyte Antigen B27 (HLA-B27) antigen present in 75-85% cases.
• HLA-B27 positivity correlates strongly with axial disease severity, extra-articular manifestations, and chronicity.
• Tumor necrosis factor (TNF) c1 allele and Transporter Associated with Antigen Processing (TAP2) polymorphism implicated in pathogenesis.

Pathogenesis

Mechanism Of Injury

• Incomplete elimination of bacteria or bacterial products (DNA/antigens) drives chronic inflammation.
• Bacterial mucosal invasion initiates inflammatory cascade.
• Release of proinflammatory cytokines, predominantly Interleukin-23 (IL-23) and Interleukin-17 (IL-17).
• Bacterial antigenic peptide presentation to CD4+ or CD8+ T lymphocytes triggers cross-reactive autoimmune responses.
• Molecular mimicry between pathogen antigens and host joint tissues.
• Chlamydia trachomatis uniquely persists in monocytes, traveling directly to synovium to incite local inflammatory response.

Etiological Agents

Organisms Triggering Classical Reactive Arthritis

Infection Source	Common Pathogens	Less Common Pathogens
Gastrointestinal	Salmonella enteritidis, Shigella flexneri, Yersinia enterocolitica, Campylobacter jejuni	Clostridium difficile, Giardia lamblia, Cryptosporidium, Entamoeba histolytica
Genitourinary	Chlamydia trachomatis	Neisseria gonorrhoeae, Ureaplasma urealyticum, Mycoplasma genitalium
Respiratory	Chlamydia pneumoniae, Mycoplasma pneumoniae	Streptococcus pyogenes

Clinical Manifestations

Disease Chronology

• Latent period averages 3-4 weeks post-infection, ranging from 3 days to 6 weeks.
• Arthritis symptoms may overlap with active initial infection (e.g., ongoing bloody dysentery).

Articular Features

• Asymmetric oligoarthritis or monoarthritis.
• Marked predilection for lower extremity weight-bearing joints (knees, ankles).
• Non-migratory, additive progression pattern.
• Dactylitis (diffuse sausage-like digit swelling) observed in up to 40%.
• Enthesitis highly prevalent (up to 90%), predominantly affecting Achilles tendon or plantar fascia insertion.
• Sacroiliitis occurs in 20% cases, primarily in HLA-B27 positive individuals.

Extra-Articular Features

Organ System	Specific Manifestations
Mucocutaneous	Keratoderma blennorrhagica (hyperkeratotic scaly plaques on soles/palms resembling pustular psoriasis), erythema nodosum, painless oral ulcers, nail pitting/onycholysis
Genitourinary	Urethritis, cervicitis, vaginitis, circinate balanitis (painless shallow ulcers on glans penis affecting 20-30% males)
Ocular	Acute symptomatic anterior uveitis, conjunctivitis, episcleritis
Constitutional	High fever, severe malaise, fatigue, significant weight loss
Cardiac	Aortic valve involvement, myocarditis, pericarditis (rare, occasionally seen with Salmonella)

Diagnostic Evaluation

Berlin Criteria (1995)

• Asymmetric peripheral arthritis (predominantly lower limb).
• Evidence of preceding infection (clinical history of diarrhea/urethritis within 4 weeks or laboratory confirmation).
• Strict exclusion of other defined spondyloarthropathies.

Laboratory Investigations

• Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and platelets markedly elevated reflecting systemic inflammation.
• Complete blood count reveals neutrophilic leukocytosis; severe cases manifest anemia of chronic disease.
• Autoantibodies (Antinuclear Antibody, Rheumatoid Factor) consistently test negative.
• HLA-B27 genetic testing positive in up to 80-85%.

Microbiological Workup

• Stool culture essential for identifying enteric pathogens.
• Urine nucleic acid amplification test (NAAT) or urethral swab for Chlamydia/Gonococcus DNA detection via polymerase chain reaction (PCR).
• Specific serological markers (hemagglutination) for Salmonella and Yersinia.
• Synovial fluid analysis: Turbid fluid, extremely high leukocyte counts (often >50,000/microL with neutrophil predominance), but sterile routine bacterial cultures. Synovial fluid PCR may detect offending bacterial DNA.

Radiologic Evaluation

• Plain radiographs demonstrate non-specific joint effusion, soft tissue swelling, or widened joint space.
• Ultrasonography confirms joint effusion, tenosynovitis, and localized enthesitis.
• Chronic stages reveal spur formation at plantar fascia insertion, erosions, or sacroiliac joint changes identical to ankylosing spondylitis.

Post-Streptococcal Reactive Arthritis (PSReA)

Characteristics

• Non-purulent complication following Group A Beta-Hemolytic Streptococcus (GABHS) upper respiratory tract infection.
• Specifically fails to fulfill revised Jones criteria for Acute Rheumatic Fever (ARF) diagnosis.
• Bimodal age distribution: Early peak at 8-14 years, late peak at 21-37 years.
• Genetic vulnerability linked to inheritance of HLA-DRB1*01 allele.

Differentiation From Acute Rheumatic Fever

Clinical Parameter	Post-Streptococcal Reactive Arthritis (PSReA)	Acute Rheumatic Fever (ARF)
Latent Period	Short (<10 days)	Long (2-3 weeks)
Arthritis Pattern	Additive, persistent, non-migratory	Fleeting, highly migratory
Joint Distribution	Large joints, significant axial skeleton/small joint involvement	Exclusively large joints (knees, ankles, wrists)
Response To Salicylates	Poor to moderate, incomplete resolution	Dramatic, rapid symptom resolution
Carditis Risk	Rare (~8%), late subclinical presentation	Common, potentially severe
Duration Of Arthritis	Prolonged (>2 months)	Brief (1-2 weeks untreated)

Specific Management Of PSReA

• Joint symptoms exhibit poor response to standard Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
• Systemic corticosteroid therapy provides favorable, rapid relief.
• Secondary antibiotic prophylaxis recommended for 1-2 years following primary episode; extended prophylaxis indicated if valvular heart disease develops prospectively.

General Management Principles

Pharmacotherapy

• NSAIDs represent first-line symptomatic therapy for pain and inflammation control.
• Intra-articular corticosteroid injections (triamcinolone hexacetonide) administered for refractory mono/oligoarthritis following definitive exclusion of septic arthritis.
• Short course low-dose systemic corticosteroids (5-10 mg daily for 1-2 weeks) hasten recovery in severe, incapacitating acute episodes.
• Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) (methotrexate, sulfasalazine) indicated for chronic persistent arthritis, severe keratoderma blennorrhagica, or refractory uveitis.
• Biologic agents (TNF inhibitors: infliximab, adalimumab) reserved for severe axial disease, treatment-resistant enthesitis, or complete DMARD failure.
• Systemic antimicrobials indicated exclusively for documented, ongoing antecedent infections (e.g., active Chlamydial urethritis). Routine antibiotic administration does not alter long-term joint disease trajectory.

Supportive Care

• Early mobilization, active physical therapy, and customized orthotics (heel cups) preserve joint function and prevent localized muscle atrophy.

Prognosis And Complications

• Usually follows self-limiting monophasic course, resolving completely within 6 weeks in pediatric populations.
• Chronic or recurrent arthritis/enthesitis develops in 15-30% of patients.
• Direct progression to Enthesitis-Related Arthritis (ERA) or fully expressed Juvenile Idiopathic Arthritis (JIA) documented in subset of cases.
• Chronicity risk factors include HLA-B27 genetic positivity and presence of extra-articular manifestations (triad of arthritis, urethritis, conjunctivitis).
• Uveitis related to reactive arthritis generally maintains benign course without permanent ocular sequelae.